Fraser Macfarlane Email & Phone Number

London, England, GB

Brentford, Middlesex, GB

Successfully led the overall operational demerger of GSK & Haleon; the largest corporate demerger in recent European stock market history with responsibility for the overall design, implementation and operational separation budget as well as leading a combined cross-functional team ~ 700 FTEs. Achieved significant annual savings by leading two R&D.

Brentford, Middlesex, GB

Led the global R&D project and resource management function to enhance the quality of GSK´s drug planning and delivery environment (~120 FTEs). Established project management as an accredited function with mandated training leading to majority of members with PMI certification within 2yrs. Established an integrated resource management framework to track.

Brentford, Middlesex, GB

Led the GSK Japan clinical development function (~100 FTEs) in becoming more integrated into the central GSK organisation, embracing pipeline prioritisation, people development and efficient project execution. This ensured that Japan regulatory submissions were able to be simultaneously submitted alongside the US and EU regulatory filings. Led a.

Brentford, Middlesex, GB

Board member of the GSK IP companies to and ensure appropriate management of the overall GSK IP portfolio and alignment to the UK Patent Box initiative.

Brentford, Middlesex, GB

Responsible for R&D portfolio management, analytics and investment decision making across Pharma R&D (influencing ~£3b annual budget) working closely with the CEO, CFO, Commercial and R&D Heads. Drove GSK pipeline prioritisation and resource allocation which led to 6 NMEs being launched in 12 months during 2012-13 (Breo, Mekinist, Tafinlar, Tivicay, Anoro.

Brentford, Middlesex, GB

• Member of the Biopharm R&D Executive Team (influencing ~£0.4b annual budget) and led the Biopharm Investment Board and the entire GSK Product Management/Investment Boards and governance.
• Led GSK pipeline prioritisation, alliance and resource management for Biopharm portfolio; increasing the clinical pipeline from 8% to >25% in 2 years through significant business development and indication.

Brentford, Middlesex, GB

Member of the Development Executive Team and chief of staff to the Heads of Global Product Strategy and Development/Chief Medical Officer (influencing ~£1b R&D budget). Headed team (~35 FTEs) responsible for pipeline governance, communications, capacity management, portfolio/project management and change management. Led the transformation project to create.

Brentford, Middlesex, GB

• Senior member of a small, internal consultancy group responsible for supporting the R&D Executive to resolve cross-R&D strategic, performance and operational issues. These included £1b investment in 4 high throughput.

Brentford, Middlesex, GB

Responsible for driving the acceptance of performance measurement and operational improvement within Glaxo Wellcome R&D. Delivered on a number of strategic projects that led to significant investments in pipeline productivity. Achieved two candidate selections in rheumatoid arthritis and one Phase I start as project manager.

Provided benchmarking and consultancy to the leading 40 leading pharmaceutical companies on the effectiveness and efficiency of pharmaceutical R&D. Established industry benchmark databases on success rates, clinical, asset cycle times and R&D investment trends that are still used by pharmaceutical executives today.

Phd, Welsh School Of Pharmacy

Msc, Clinical Pharmacology

Bsc, Pharmacology & Physiology

Newcastle Upon Tyne